E
ENGN//CIK 0001980845
enGene Therapeutics Inc.
Market Data
$7.27+$0.22 (+3.12%)
ENGN · Last trade
Prev Close
$7.05
Range (30d)
$6.18 – $7.33
Recent Filings
- 8-K1.3 MBenGene Therapeutics Inc.Apr 9, 4:02 PM ET·0001193125-26-149597
- 8-K735.4 KBenGene Holdings Inc.Mar 9, 7:15 AM ET·0001193125-26-097546
- 10-Q10.3 MBenGene Holdings Inc.Mar 9, 7:09 AM ET·0001193125-26-097541
- 8-K356.3 KBenGene Holdings Inc.Mar 9, 7:04 AM ET·0001193125-26-097534
- 10-K/A1.3 MBenGene Holdings Inc.Feb 19, 4:15 PM ET·0001193125-26-059409
- 8-K1.5 MBenGene Holdings Inc.Jan 21, 4:05 PM ET·0001193125-26-017945
- 8-K250.2 KBenGene Holdings Inc.Jan 21, 7:38 AM ET·0001193125-26-017226
- 10-K17.1 MBenGene Holdings Inc.Dec 22, 4:11 PM ET·0001193125-25-328743
- 8-K359.8 KBenGene Holdings Inc.Dec 22, 4:04 PM ET·0001193125-25-328706
- 8-K729.4 KBenGene Holdings Inc.Nov 14, 4:39 PM ET·0001193125-25-283182
Insiders
10- Astley-Sparke PhilipDirector
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- Bos JasperDirector
- Boyd Matthew RossChief Regulatory Officer
- BRUNK GERALD ADirector
- BRYCE RICHARD PAULChief Medical Officer
- Buck JillChief Development Officer
- BVF GP HOLDINGS LLC10% Owner
- BVF I GP LLCSee Explanation of Responses
Tickers
Addresses
business
4868 RUE LEVY, SUITE 220
SAINT-LAURENT
mailing
4868 RUE LEVY, SUITE 220
SAINT-LAURENT
Former Names
- enGene Holdings Inc.2026-03-09